Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy Grant

Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy Grant

Status: ACTIVE
Funder: Pfizer, Inc.
Amount: Up to US $100,000
Last Updated: March 10, 2026

Summary

This program aims to enhance education for healthcare professionals regarding new therapies and patient management in ulcerative colitis (UC). It focuses on multi-channel educational strategies to address the evolving landscape of UC treatment. Key areas include educating on new oral therapies, transitioning to advanced therapies, and managing isolated proctitis. Organizations such as healthcare institutions and medical education companies are eligible to apply, ensuring a comprehensive approach to improving UC care.

Overview

A significant knowledge gap persists among healthcare professionals regarding the baseline evaluations required when initiating sphingosine 1-phosphate receptor modulator (S1Prm) therapy for the treatment of moderately to severely active ulcerative colitis in adults. Education is needed on the role of electrocardiogram (ECG) and conduction assessment for appropriate patient identification prior to initiation. In addition, education is needed on performing an ECG, eye exam, and skin exam prior to starting S1Prm therapy in adults with ulcerative colitis. This competitive program invites interdisciplinary independent medical education proposals aimed at strengthening the competency of healthcare professionals involved in the management of adults with ulcerative colitis who are initiating S1Prm therapy. Project Types and Area of Interest Educational projects eligible for Pfizer support should integrate expertise from specialists (e.g., gastroenterology, cardiology, electrophysiology, S1Prm pharmacology, dermatology, ophthalmology, etc) to deliver comprehensive education on baseline assessments, especially ECG, outlined in the current U.S. Prescribing Information for S1Prm therapy. Specific Area of Interest for this RFP: Educational projects eligible for Pfizer support should address the following components: Educational Leads: Programs should be led by interdisciplinary key opinion leaders with expertise in relevant assessments (e.g., gastroenterology, cardiology, electrophysiology, dermatology, ophthalmology, and S1Prm pharmacology).Educational Content: Projects should provide thorough coverage of the required assessments, such as cardiological aspects outlined in the current U.S. prescribing information for S1Prm therapy. This may include interpretation of cardiology surveillance data, detailed discussion of ECG requirements (e.g., type of ECG, timing flexibility prior to treatment initiation) and recommended best clinical practices. Educational Outcomes: Applicants are encouraged to define clear educational metrics, such as estimated learner reach, demonstrated increases in knowledge through pre- and post-activity assessments, and the projected number of patients potentially affected by improved clinical practices. Publication of data driven commentary or perspective article authored by the educational leads is strongly encouraged to disseminate insights and further advance discourse in the field. Accreditation: Both accredited and non-accredited continuing medical education (CME/CE) activities will be considered.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website. Only organizations are eligible to receive grants, not individuals or medical practice groups.The following may apply:medical, nursing, allied health, and/or pharmacy professional schoolshealthcare institutions (both large and small)professional organizations/medical societiesmedical education companiesother entities with a mission related to healthcare professional education and/or healthcare improvementIf the project involves multiple departments within an institution and/or between different institutions organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).The project/program lead must be an employee or independent contractor of the requesting organization.Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.For projects offering continuing education credit, the requesting organization must be accredited.